arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PepGen Inc.

PEPG
$2.85 ▲ +0.45 (+18.50%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
6 Visible periods
19 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

PepGen Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $120.3M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -63.5%
FCF / Share $-1.94
Trailing P/E
Price / Book 1.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-89.66M
— +0.4%
FCF / Share Free cash flow per share
$-1.94
↑ +26.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Cash Quality
61

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters